An evaluation of torsemide in patients with heart failure and renal disease

AE Peters, RJ Mentz, TA DeWald… - Expert review of …, 2022 - Taylor & Francis
Introduction Torsemide is a loop diuretic that inhibits the Na+/K+/2Cl− cotransporter type 2 in
the thick ascending loop of Henle, leading to increased excretion of urinary sodium and …

Practical outpatient management of worsening chronic heart failure

N Girerd, N Mewton, J Tartière… - European Journal of …, 2022 - Wiley Online Library
Management of worsening heart failure (WHF) has traditionally been hospital‐based, but
with the rising burden of heart failure (HF), the pressure on healthcare systems exerted by …

Development of an immunochromatographic assay for the rapid screening of torasemide in health food

J Yan, A Wu, L Liu, L Xu, H Kuang, C Xu, L Guo - Food Chemistry, 2024 - Elsevier
Torasemide is a new loop diuretic agent added illegally to health foods for weight loss,
which can result in serious health risks for consumers. A rapid and sensitive …

Tricuspid Regurgitation: A Review of Current Interventional Management

M Ambrosino, M Sangoi, N Monzer… - Journal of the …, 2024 - Am Heart Assoc
Tricuspid regurgitation is a common yet clinically complex problem, traditionally managed
with diuretic therapy with no observable mortality benefit. Older studies on surgical …

Clinical Outcomes with Furosemide Versus Torsemide in Patients with Heart Failure: An Updated Systematic Review and Meta-Analysis

AK Siddiqi, H Javaid, M Ahmed, S Dhawadi… - Current Problems in …, 2023 - Elsevier
Background and objective Despite potential advantages of torsemide over furosemide,<
10% of the patients with heart failure (HF) are on torsemide in clinical practice. Prior studies …

A Systematic Critical Review of Clinical Pharmacokinetics of Torasemide

AW Sherazi, A Zamir, A ur Rehman… - Therapeutic Drug …, 2024 - journals.lww.com
Purpose: Torasemide is a potassium-sparing loop diuretic used to treat fluid retention
associated with congestive heart failure and kidney and hepatic diseases. This systematic …

[HTML][HTML] Torasemide-induced IgA vasculitis in a patient with heart failure

YU Lin-Yu, LIU Liang-Yu, TAN Deng-Hang… - Journal of Geriatric …, 2023 - ncbi.nlm.nih.gov
Heart failure (HF) is a widespread clinical syndrome worldwide that imposes an enormous
burden on healthcare systems.[1, 2] Loop diuretics are one of the cornerstones for treating …

Wirkmechanismen und klinische Anwendung von Diuretika in der Intensivmedizin

ML Lindner, JL Lohmeyer, EH Adam… - Die …, 2023 - Springer
Die paarig angelegten Nieren nehmen aufgrund der Vielzahl ihrer physiologischen
Aufgaben im menschlichen Körper eine Sonderrolle ein. Über komplexe biochemische …

Which loop diuretic to give preference to: review of evidence-based medicine data| Ukrainian Medical Journal

TL Mozhyna - Which loop diuretic to give preference to: review of …, 2023 - umj.com.ua
Diuretics belong to the first-line therapy of arterial hypertension, heart failure, edema,
maintenance of target blood pressure in chronic kidney disease, and reduction of edema in …

Which loop diuretic to give preference to: review of evidence-based medicine data| Український Медичний Часопис

TL Mozhyna - Which loop diuretic to give preference to: review of …, 2023 - umj.com.ua
Резюме Diuretics belong to the first-line therapy of arterial hypertension, heart failure,
edema, maintenance of target blood pressure in chronic kidney disease, and reduction of …